Of note, increased BRG1 levels and decreased BRM levels were also positively related to metastasis of HCC patients (Fig. 7e) and expression levels of YAP1 targets showed the same trend as BRG1 (Fig. 7f). Here, SMARCA2 is linked to hepatocellular carcinoma.